Expertise in
14
conditions

Dr. Srini B. Reddy

Oncology
Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, 
Amarillo, TX 
Accepting New Patients
Offers Telehealth
Expertise in
14
conditions
Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, 
Amarillo, TX 

Overview

Srini Reddy is an Oncologist practicing medicine in Amarillo, Texas.

Dr. Reddy is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 3 clinical trials. Dr. Reddy is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TX

Hospital Affiliations

Ochiltree General Hospital
Bsa Hospital
Northwest Texas Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Texas Oncology Pharmacy-Amarillo
1826 Point West Pkwy, Amarillo, TX 79124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
Enrollment Status: Withdrawn
Publish Date: September 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

3 Total Publications

Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentation.
Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentation.
Journal: International journal of surgery case reports
Published: May 17, 2017
Similar Doctors
Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required

Bsa Harrington Cancer Center

1751 Wallace Blvd, 
Amarillo, TX 
 (0.5 miles away)
806-212-4673
Languages Spoken:
English
See accepted insurances

Anita Ravipati is an Oncologist practicing medicine in Amarillo, Texas. Dr. Ravipati is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Familial Colorectal Cancer.

Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Texas Oncology Pharmacy-Amarillo

1826 Point West Pkwy, 
Amarillo, TX 
 (0.1 miles away)
806-358-8654
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Praveen Tumula is an Oncologist practicing medicine in Amarillo, Texas. Dr. Tumula is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Lung Cancer, and Bone Marrow Aspiration. Dr. Tumula is currently accepting new patients.

Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required

Bsa Harrington Cancer Center

1751 Wallace Blvd, 
Amarillo, TX 
 (0.5 miles away)
806-212-4673
Languages Spoken:
English
See accepted insurances

Milan Patel is an Oncologist practicing medicine in Amarillo, Texas. Dr. Patel is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Colorectal Cancer, Neuroendocrine Tumor, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Srini B. Reddy

How do I make an appointment with Dr. Srini B. Reddy?

You can book an appointment with Dr. Srini B. Reddy by calling their office at 806-358-8654. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Srini B. Reddy a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Srini B. Reddy is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Srini B. Reddy specialize in?

While Dr. Srini B. Reddy is a Oncology, they have specific expertise in Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Srini B. Reddy participate in research or clinical trials?

Yes. Dr. Srini B. Reddy has published 3 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Srini B. Reddy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Srini B. Reddy accept my insurance?

Dr. Srini B. Reddy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 806-358-8654 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reddy's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 76 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile